Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 4, 2011, Pages 606-609

  Oron, Galia ^a   Ben Haroush, Avi ^a   Goldfarb, Rachel ^a   Molad, Yair ^b   Hod, Moshe ^a   Bar, Jacob ^c  

^a Helen Schneider Hospital for Women   (Israel)

^b Rheumatology Unit   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Anti 2 glycoprotein 1; antiphospholipid syndrome; complications; pregnancy

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FETUS DEATH; HUMAN; INTRAUTERINE GROWTH RETARDATION; LABORATORY TEST; MAJOR CLINICAL STUDY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

ABRUPTIO PLACENTAE; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; COHORT STUDIES; FEMALE; FETAL DEATH; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 79952405694     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.511339     Document Type: Article

References (23)

1. Rand JH. The antiphospholipid syndrome. Annu Rev Med 2003;54:409-424. (Pubitemid 37386404)
2. Galli M. Antiphospholipid syndrome: association between laboratory tests and clinical practice. Pathophysiol Haemost Thromb 2003/2004;33:249-255. (Pubitemid 40278691)
3. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311. (Pubitemid 30265586)
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
5. Zohlami-Rintelen C, Vormittag R, Sailer T, Lehr S, Quehenberger P, Rumpold H, Male C, Pabinger I. The presence of IgG antibodies against b2 glycoprotein I predicts the risk of thrombosis in patients with lupus anticoagulant. J Thromb Haemost 2005;3:1160-1165. (Pubitemid 41725235)
6. Levy RA, Avvad E, Oliveira J, Porto LC. Placental pathology in antiphospholipid syndrome. Lupus 1998;7:81-85.
7. Lockshin MD. Pregnancy loss and antiphospholipid antibodies. Lupus 1998;7:86-89.
8. Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J 2005;7:311-314. (Pubitemid 40668153)
9. Report on the National High Blood Pressure Education Program Working Group On High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
10. Brandt JT, Triplett DA, Alvin B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-1190.
11. Pengo V, Biasiolo A, Rampazzo P, Brocco T. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-b2-Glycoprotein-I autoantibodies. Thromb Haemost 1999;81:256-258. (Pubitemid 29078313)
12. Tincani A, Allegri F, Balestrieri G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004;114:553-558. (Pubitemid 39422591)
13. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC; Standardization group of the European Forum on Antiphospholipid Antibodies. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004;2:1860-1862. (Pubitemid 40192732)
14. Falcon CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 1997;89: 975-980. (Pubitemid 27220465)
15. Lynch A, Byers T, Emlen W, Rynes D, Shetterly SM, Hamman RF. Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension:a prospective study in low-risk pregnancy. Obstet Gynecol 1999;93:193-198. (Pubitemid 29068091)
16. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to beta2-glycoprotein- I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998;352:1037-1038. (Pubitemid 28438584)
17. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in hamster. Blood 2003;101:157-162. (Pubitemid 36025902)
18. Molad Y, Borkowski T, Monselise A, Ben-Haroush A, Sulkes J, Hod M, Feldberg D, Bar J. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005;14:145-151. (Pubitemid 40327665)
19. Danowski A, Kickler TS, Petri M. Anti b2 glycoprotein I:Prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 2006;33:1775-1779. (Pubitemid 44373210)
20. Mok MY, Chan EY, Fong DY, Leung KF, Wong WS, Lau CS. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol 2005;32:622-628. (Pubitemid 40524692)
21. Laskin CA, Spitzer KA, Clark CA, et al. Low molecular weight heparin and aspirin for the recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 2009;36:279-287.
22. Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, Stunkard AJ, D'Agostino RB. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 1993;328:1528-1533. (Pubitemid 23147782)
23. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002;325:157-160. (Pubitemid 34800133)